Intersect ENT Raises $30 Million

Funds to Fuel Commercial Expansion and Development of Next Generation Products for Chronic Sinusitis Sufferers MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat ... Devices, Venture CapitalIntersect ENT, mini sinus implants, sinusitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news